P-050 - CLINICAL IMPLICATION OF DIFFERENT TREATMENT TECHNIQUES IN GLOTTIC CANCER
P-060 - CONSULTATION OPTIMIZATION IN PATIENTS WITH HEAD AND NECK (H&N) CANCER
P-061 - CONTROVERSY IN RARE TUMORS: OUR ROLE IN PAROTID SMALL-CELL CARCINOMA
P-072 - DEFINITIVE RADIOTHERAPY IN T1 GLOTTIC CARCINOMA: LONG-TERM RESULTS AND QUALITY-OF-LIFE
P-112 - EXPERIENCE WITH INDUCTION CHEMOTHERAPY ADDED TO RADIOCHEMOTHERAPY IN NASOPHARYNGEAL CARCINOMA
P-120 - EXTREME HYPOFRACTIONATION IN HEAD AND NECK CANCER
P-132 - FLOW CONTROL AND NUTRITIONAL INTERVENTION IN ORAL CAVITY TUMOURS
P-157 - HYPOFRACTIONATED RADIOTHERAPY FOR ADVANCED HEAD AND NECK CANCER ELDERLY PATIENTS
P-159 - HYPOFRACTIONATED RADIOTHERAPY IN HEAD AND NECK CANCER
P-203 - L-GLUTAMINE SUPPLEMENTATION FOR PREVENTION AND AMELIORATION OF RADIATION-INDUCED ORAL MUCOSITIS
P-209 - LONG-TERM RESULTS IN LARYNX PRESERVATION IN PATIENTS TREATED WITH RT-QT
P-220 - MALNUTRITION AND SARCOPENIA IN HEAD AND NECK CANCER
P-229 - MORTALITY PREDICTORS RELATED WITH NUTRITION IN HEAD AND NECK CANCER
P-237 - NUTRITIONAL INTERVENTION IN HEAD&NECK CANCER PATIENTS DURING AND AFTER RADIOTHERAPY
P-255 - PAROTID SPARING ADAPTIVE RADIOTHERAPY IN HEAD AND NECK CANCERS
P-283 - PREDICTIVE VALUE OF NLR IN OROPHARYNGEAL AND ORAL CAVITY CANCER.
P-299 - PROTOCOL EXPERIENCE IN LARYNGEAL PRESERVATION
P-302 - QUALITY OF LIFE IN HEAD AND NECK CANCER
P-319 - REAL-DATA OUTCOMES OF RADIOTHERAPY FOR LARYNGEAL CARCINOMA AT OUR INSTITUTION
P-324 - REIRRADIATION IN HEAD&NECK RECURRENT CANCER OR SECOND PRIMARY. OUR EXPERIENCE.
P-339 - ROLE OF RADIOTHERAPY IN INFLAMMATORY MYOFIBLOBLASTIC TUMORS